
Bryan R. Muller
Examiner (ID: 6882, Phone: (571)272-4489 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3799, 3727 |
| Total Applications | 1400 |
| Issued Applications | 643 |
| Pending Applications | 105 |
| Abandoned Applications | 668 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8469402
[patent_doc_number] => 08298580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Sustained-release formulations of topiramate'
[patent_app_type] => utility
[patent_app_number] => 12/926931
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8883
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926931 | Sustained-release formulations of topiramate | Dec 16, 2010 | Issued |
Array
(
[id] => 7567040
[patent_doc_number] => 20110287103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Sustained-release formulations of topiramate'
[patent_app_type] => utility
[patent_app_number] => 12/926936
[patent_app_country] => US
[patent_app_date] => 2010-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8889
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287103.pdf
[firstpage_image] =>[orig_patent_app_number] => 12926936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926936 | Sustained-release formulations of topiramate | Dec 16, 2010 | Issued |
Array
(
[id] => 8239918
[patent_doc_number] => 20120148654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'METHOD AND SYSTEM FOR A PHOTORESIST-BASED IMMUNOISOLATIVE MICROCONTAINER WITH NANOSLOTS DEFINED BY NANOIMPRINT LITHOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 12/966179
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5670
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12966179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966179 | METHOD AND SYSTEM FOR A PHOTORESIST-BASED IMMUNOISOLATIVE MICROCONTAINER WITH NANOSLOTS DEFINED BY NANOIMPRINT LITHOGRAPHY | Dec 12, 2010 | Abandoned |
Array
(
[id] => 5969240
[patent_doc_number] => 20110150964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'APTAMER-COATED IMPLANT, PROCESS OF PRODUCTION, AND USES'
[patent_app_type] => utility
[patent_app_number] => 12/963949
[patent_app_country] => US
[patent_app_date] => 2010-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8393
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150964.pdf
[firstpage_image] =>[orig_patent_app_number] => 12963949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/963949 | APTAMER-COATED IMPLANT, PROCESS OF PRODUCTION, AND USES | Dec 8, 2010 | Abandoned |
Array
(
[id] => 8712870
[patent_doc_number] => 08399009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Bioceramic and biopolymer composite'
[patent_app_type] => utility
[patent_app_number] => 12/955109
[patent_app_country] => US
[patent_app_date] => 2010-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 4314
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12955109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/955109 | Bioceramic and biopolymer composite | Nov 28, 2010 | Issued |
Array
(
[id] => 10882016
[patent_doc_number] => 08906392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Nanocluster compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/954509
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 87
[patent_no_of_words] => 33766
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12954509
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954509 | Nanocluster compositions and methods | Nov 23, 2010 | Issued |
Array
(
[id] => 6000853
[patent_doc_number] => 20110117171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'IMPLANTABLE BONE GRAFT MATERIALS'
[patent_app_type] => utility
[patent_app_number] => 12/949069
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15140
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117171.pdf
[firstpage_image] =>[orig_patent_app_number] => 12949069
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/949069 | IMPLANTABLE BONE GRAFT MATERIALS | Nov 17, 2010 | Abandoned |
Array
(
[id] => 6080343
[patent_doc_number] => 20110142941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/947389
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 57564
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142941.pdf
[firstpage_image] =>[orig_patent_app_number] => 12947389
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/947389 | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof | Nov 15, 2010 | Issued |
Array
(
[id] => 5943668
[patent_doc_number] => 20110104288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Microcrystalline Cellulose and Calcium Phosphate Compositions Useful as Pharmaceutical Excipients'
[patent_app_type] => utility
[patent_app_number] => 12/917904
[patent_app_country] => US
[patent_app_date] => 2010-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12265
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104288.pdf
[firstpage_image] =>[orig_patent_app_number] => 12917904
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/917904 | Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients | Nov 1, 2010 | Issued |
Array
(
[id] => 9383494
[patent_doc_number] => 20140086975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'HYDROGEL FORMULATION FOR DERMAL AND OCULAR DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/879440
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13866
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879440
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879440 | HYDROGEL FORMULATION FOR DERMAL AND OCULAR DELIVERY | Oct 20, 2010 | Abandoned |
Array
(
[id] => 6080359
[patent_doc_number] => 20110142949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'CHONDROITINASE TREATMENT METHOD FOR DEMYELINATION-RELATED CONDITIONS AND DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/906399
[patent_app_country] => US
[patent_app_date] => 2010-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6398
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142949.pdf
[firstpage_image] =>[orig_patent_app_number] => 12906399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/906399 | CHONDROITINASE TREATMENT METHOD FOR DEMYELINATION-RELATED CONDITIONS AND DISEASES | Oct 17, 2010 | Abandoned |
Array
(
[id] => 6118641
[patent_doc_number] => 20110076314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'HYDROPHOBIC POLYSACCHARIDES WITH SILYL ETHER LINKAGES HAVING ENHANCED DEGRADATION AND MEDICAL ARTICLES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/894929
[patent_app_country] => US
[patent_app_date] => 2010-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14125
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12894929
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/894929 | Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom | Sep 29, 2010 | Issued |
Array
(
[id] => 6134510
[patent_doc_number] => 20110008412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Oral Formulations for 5-HT-Receptor Agonists, Uses and Methods of Treatment Employing The Same'
[patent_app_type] => utility
[patent_app_number] => 12/887599
[patent_app_country] => US
[patent_app_date] => 2010-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5783
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12887599
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/887599 | Oral Formulations for 5-HT-Receptor Agonists, Uses and Methods of Treatment Employing The Same | Sep 21, 2010 | Abandoned |
Array
(
[id] => 6159234
[patent_doc_number] => 20110158921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids'
[patent_app_type] => utility
[patent_app_number] => 12/807979
[patent_app_country] => US
[patent_app_date] => 2010-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14859
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20110158921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12807979
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/807979 | Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids | Sep 16, 2010 | Issued |
Array
(
[id] => 6008381
[patent_doc_number] => 20110060412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Tissue Engineered Meniscus Repair Composition'
[patent_app_type] => utility
[patent_app_number] => 12/875829
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6748
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12875829
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/875829 | Tissue Engineered Meniscus Repair Composition | Sep 2, 2010 | Abandoned |
Array
(
[id] => 5928979
[patent_doc_number] => 20110038938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'Compositions for tissue augmentation'
[patent_app_type] => utility
[patent_app_number] => 12/859004
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12859004
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/859004 | Compositions for tissue augmentation | Aug 17, 2010 | Abandoned |
Array
(
[id] => 8429712
[patent_doc_number] => 20120251587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'DIABETES TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/391269
[patent_app_country] => US
[patent_app_date] => 2010-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8684
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391269
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/391269 | Diabetes treatment | Aug 16, 2010 | Issued |
Array
(
[id] => 5928962
[patent_doc_number] => 20110038921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD'
[patent_app_type] => utility
[patent_app_number] => 12/856299
[patent_app_country] => US
[patent_app_date] => 2010-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 29754
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12856299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/856299 | METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD | Aug 12, 2010 | Abandoned |
Array
(
[id] => 7800636
[patent_doc_number] => 08128906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Stabilized uncoated particles of reversed liquid crystalline phase materials'
[patent_app_type] => utility
[patent_app_number] => 12/854631
[patent_app_country] => US
[patent_app_date] => 2010-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30322
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/128/08128906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12854631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/854631 | Stabilized uncoated particles of reversed liquid crystalline phase materials | Aug 10, 2010 | Issued |
Array
(
[id] => 7800635
[patent_doc_number] => 08128905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Stabilized uncoated particles of reversed liquid crystalline phase materials'
[patent_app_type] => utility
[patent_app_number] => 12/854369
[patent_app_country] => US
[patent_app_date] => 2010-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 30331
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/128/08128905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12854369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/854369 | Stabilized uncoated particles of reversed liquid crystalline phase materials | Aug 10, 2010 | Issued |